Funded Tech Companies
Keros Therapeutics
Wondering who provided funding to Keros Therapeutics? Medison Pharma, Pontifax Fund and Arkin Bio-Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Keros Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
99 Hayden Ave. Building E 120
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Keros Therapeutics (Nasdaq: KROS) harnesses the knowledge of leading physician researchers and medical experts in the discovery and development of novel proprietary therapeutics for neuromuscular diseases. Headquartered in Lexington, Massachusetts, Keros Therapeutics is led by President and CEO Dr. Jasbir Seehra, who has over three decades of hands-on experience creating first-tier drug therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/7/2020
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jasbir Seehra
Chief Financial Officer
Keith Regnante
Chief Medical Officer
Claudia Ordonez
Vice President
Jenn Lachey
Company Investors
- Medison Pharma
- Pontifax Fund (Ran Nussbaum)
- Arkin Bio-Ventures
- Global Health Sciences Fund
- Partners Innovation Fund
Browse more funded tech companies:
Kerogen Resources | Kerv Interactive
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs